CorVel Corporation — Form 10-Q Summary
Period clarification: The supplied filing is for the quarter ended December 31, 2016 (CorVel fiscal 2017 third quarter), not 2015 Q3 as stated in the request metadata. Comparisons below are against the quarter and nine months ended December 31, 2015.
Business context and reporting period
CorVel provides medical cost containment and managed care services, including network solutions and patient management, to insurers, third-party administrators, government entities, and self-insured employers. It reports one operating segment: managed care. Management notes a continuing long-term decline in U.S. workplace injury rates.
Financial performance
| Metric | Three months ended Dec. 31, 2016 | Year-over-year change | Nine months ended Dec. 31, 2016 | Year-over-year change |
|---|---|---|---|---|
| Revenue | $128.4 million | +3.6% | $385.1 million | +2.6% |
| Gross profit / margin | $25.6 million / 19.9% | +1.4%; down from 20.4% | $77.1 million / 20.0% | -1.3%; down from 20.8% |
| Income before tax | $11.4 million | +6.6% | $34.8 million | -1.7% |
| Net income | $7.0 million | +5.4% | $21.5 million | -1.7% |
| Diluted EPS | $0.36 | Up from $0.34 | $1.09 | Unchanged |
Quarterly patient management revenue rose 5.5% to $71.4 million, primarily from TPA services, partly offset by lower case management services. For the nine-month period, patient management revenue increased 3.6% to $214.6 million and network solutions revenue increased 1.3% to $170.4 million. Quarterly cost of revenues grew faster than revenue, reflecting a greater mix of lower-margin TPA work, weaker case management margins, and higher field-operation staffing costs. Lower general and administrative expenses partly offset this pressure.
Cash flow and liquidity: Nine-month operating cash flow was $35.6 million, versus $36.8 million a year earlier. Investing cash outflow was $17.4 million, including $17.2 million of property and equipment purchases; financing cash outflow was $12.2 million, including $15.1 million of share repurchases. Cash increased $6.0 million to $38.8 million from March 31, 2016. Working capital was $48.1 million, up from $42.7 million.
Balance sheet and debt: At December 31, 2016, total assets were $237.7 million and total liabilities were $94.7 million. The company reported no debt outstanding and no borrowings on its $10 million revolving credit facility; $4.5 million of letters of credit were issued separately from the facility. The renewed facility expires in September 2017, and the company reported compliance with its covenants.
Material changes and capital allocation
- For the quarter, revenue and net income increased, while gross margin declined by 0.5 percentage points. For the nine months, revenue increased but gross profit and net income declined.
- Share repurchases reduced diluted weighted-average shares by 1.5% for the quarter and 2.0% for the nine months. The company repurchased 420,098 shares for $15.1 million during the nine months; after quarter-end it repurchased a further 113,765 shares for $4.2 million.
- Cash capital spending increased from $11.9 million to $17.2 million year over year, primarily due to software license renewals. The filing also discloses a $3.5 million software license purchase under a finance agreement.
- Contractual obligations totaled $55.0 million, including $49.4 million of operating leases, $3.5 million of software licenses, and $2.1 million of uncertain tax positions.
Outlook, commentary, risks, and contingencies
No specific revenue or earnings guidance is provided. Management believes cash, anticipated operating cash flow, employee stock-option proceeds, and the credit facility will be sufficient for expected needs for at least the next 12 months. The company says results for the interim periods are not necessarily indicative of full-year results. Third-quarter seasonality includes fewer working days due to holidays, vacations, and weather.
Management identifies risks including declining workplace injury and workers’ compensation claim volumes, customer insourcing or contract loss, pricing and competitive pressure, lower-margin service mix, labor availability and cost, regulatory or legislative changes, technology and information-security disruptions, and litigation or professional-liability exposure. Ordinary-course litigation is disclosed; management does not expect its resolution to materially affect financial position or results. The company reported no indicators of impairment in goodwill or long-lived assets at December 31, 2016.
Management stated that disclosure controls were effective and that no material change in internal control over financial reporting occurred during the quarter. The company was evaluating the impact of several new accounting standards, including revenue recognition and leases; it had not estimated the impact of adoption of the revenue standard.
Important facts for investors to verify
- Confirm the period: the filing covers the quarter ended December 31, 2016, despite the 2015 Q3 metadata.
- Assess whether TPA-driven growth can continue without further erosion in gross margin and case management profitability.
- Track operating cash conversion, elevated capital spending, and the effect of continued share repurchases on cash and liquidity.
- Review the September 2017 credit facility renewal and the company’s ability to meet lease and software-license obligations.
- Monitor claim-volume trends, customer retention and outsourcing decisions, and the operational, regulatory, and litigation risks described by management.